Constantine Davides
Stock Analyst at Citizens JMP
(0.09)
# 4,533
Out of 4,596 analysts
175
Total ratings
37.9%
Success rate
-13.3%
Average return
Main Sectors:
Stocks Rated by Constantine Davides
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NRC NRC Health | Maintained: Buy | $23 → $26 | $19.51 | +33.26% | 2 | Jul 29, 2026 | |
| OMDA Omada Health | Maintained: Buy | $21 → $27 | $19.84 | +36.09% | 3 | Jul 20, 2026 | |
| HQY HealthEquity | Maintained: Buy | $122 → $111 | $100.61 | +10.33% | 9 | Jun 1, 2026 | |
| PGNY Progyny | Maintained: Buy | $30 → $31 | $31.13 | -0.42% | 8 | May 11, 2026 | |
| USPH U.S. Physical Therapy | Maintained: Buy | $113 → $98 | $79.06 | +23.96% | 6 | May 8, 2026 | |
| ADUS Addus HomeCare | Maintained: Buy | $150 → $142 | $115.48 | +22.97% | 8 | May 6, 2026 | |
| OPCH Option Care Health | Maintained: Buy | $38 → $32 | $23.03 | +38.95% | 17 | Apr 30, 2026 | |
| AMN AMN Healthcare Services | Maintained: Buy | $22 → $24 | $33.63 | -28.64% | 18 | Feb 23, 2026 | |
| WAY Waystar Holding | Maintained: Buy | $48 → $34 | $21.11 | +61.06% | 3 | Feb 18, 2026 | |
| EVH Evolent Health | Maintained: Buy | $11 → $10 | $3.09 | +223.62% | 14 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 → $24 | $6.05 | +296.69% | 14 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $31 | $23.67 | +30.97% | 11 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $18.23 | n/a | 6 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $8.10 | n/a | 7 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $91.61 | n/a | 9 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $28.04 | n/a | 6 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $1.07 | n/a | 1 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $0.3807 | n/a | 1 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 | $0.7015 | n/a | 5 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $40.73 | n/a | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $20.97 | n/a | 4 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.25 | $1.52 | n/a | 2 | Apr 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.000001 | n/a | 3 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8.5 | $2.44 | n/a | 1 | Mar 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.7181 | n/a | 2 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $2.08 | n/a | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $33 | $0.8007 | n/a | 3 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $68 | $0.8457 | n/a | 1 | Oct 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $8 | $1.52 | n/a | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4.25 | $1.89 | n/a | 1 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.3 | $0.4599 | n/a | 1 | Aug 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 | $1.10 | n/a | 1 | Mar 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $41 | $60.25 | n/a | 1 | Sep 27, 2011 |
NRC Health
Jul 29, 2026
Maintained: Buy
Price Target: $23 → $26
Current: $19.51
Upside: +33.26%
Omada Health
Jul 20, 2026
Maintained: Buy
Price Target: $21 → $27
Current: $19.84
Upside: +36.09%
HealthEquity
Jun 1, 2026
Maintained: Buy
Price Target: $122 → $111
Current: $100.61
Upside: +10.33%
Progyny
May 11, 2026
Maintained: Buy
Price Target: $30 → $31
Current: $31.13
Upside: -0.42%
U.S. Physical Therapy
May 8, 2026
Maintained: Buy
Price Target: $113 → $98
Current: $79.06
Upside: +23.96%
Addus HomeCare
May 6, 2026
Maintained: Buy
Price Target: $150 → $142
Current: $115.48
Upside: +22.97%
Option Care Health
Apr 30, 2026
Maintained: Buy
Price Target: $38 → $32
Current: $23.03
Upside: +38.95%
AMN Healthcare Services
Feb 23, 2026
Maintained: Buy
Price Target: $22 → $24
Current: $33.63
Upside: -28.64%
Waystar Holding
Feb 18, 2026
Maintained: Buy
Price Target: $48 → $34
Current: $21.11
Upside: +61.06%
Evolent Health
Jan 6, 2026
Maintained: Buy
Price Target: $11 → $10
Current: $3.09
Upside: +223.62%
Nov 7, 2025
Maintained: Buy
Price Target: $23 → $24
Current: $6.05
Upside: +296.69%
Nov 7, 2025
Maintained: Buy
Price Target: $30 → $31
Current: $23.67
Upside: +30.97%
Jul 15, 2025
Reiterated: Hold
Price Target: n/a
Current: $18.23
Upside: n/a
May 6, 2025
Maintained: Hold
Price Target: n/a
Current: $8.10
Upside: n/a
Apr 28, 2025
Reiterated: Hold
Price Target: n/a
Current: $91.61
Upside: n/a
Feb 25, 2025
Maintained: Hold
Price Target: n/a
Current: $28.04
Upside: n/a
May 25, 2023
Initiated Coverage: Buy
Price Target: $18
Current: $1.07
Upside: n/a
May 16, 2023
Maintained: Buy
Price Target: $19
Current: $0.3807
Upside: n/a
May 16, 2023
Reiterated: Buy
Price Target: $125
Current: $0.7015
Upside: n/a
May 11, 2023
Reiterated: Buy
Price Target: $15
Current: $40.73
Upside: n/a
May 10, 2023
Reiterated: Buy
Price Target: $23
Current: $20.97
Upside: n/a
Apr 18, 2023
Reiterated: Buy
Price Target: $5.25
Current: $1.52
Upside: n/a
Mar 30, 2023
Reiterated: Buy
Price Target: $6
Current: $0.000001
Upside: n/a
Mar 20, 2023
Initiated Coverage: Buy
Price Target: $8.5
Current: $2.44
Upside: n/a
Mar 16, 2023
Reiterated: Buy
Price Target: $6
Current: $0.7181
Upside: n/a
Feb 15, 2023
Reiterated: Buy
Price Target: $15
Current: $2.08
Upside: n/a
Dec 30, 2022
Maintained: Buy
Price Target: $50 → $33
Current: $0.8007
Upside: n/a
Oct 18, 2022
Initiated Coverage: Buy
Price Target: $68
Current: $0.8457
Upside: n/a
Sep 28, 2022
Maintained: Buy
Price Target: $14 → $8
Current: $1.52
Upside: n/a
Sep 23, 2022
Maintained: Buy
Price Target: $4.25
Current: $1.89
Upside: n/a
Aug 18, 2022
Maintained: Buy
Price Target: $2.3
Current: $0.4599
Upside: n/a
Mar 14, 2022
Initiated Coverage: Buy
Price Target: $4
Current: $1.10
Upside: n/a
Sep 27, 2011
Initiated Coverage: Buy
Price Target: $41
Current: $60.25
Upside: n/a